Integrated analysis of laser-captured glomerular proteome characterizes the expression and functional role of APOE in membranous nephropathy

Background MN is a prevalent primary glomerular disease causing adult nephrotic syndrome. Clinically, invasive renal biopsy acts as the pathological gold standard, while the widely used serological anti-PLA2R antibody has limited sensitivity and cannot reflect glomerular lesion severity. Conventional immunosuppressive regimens face frequent drug resistance and relapse, and core tissue-derived pathogenic regulators remain poorly defined. This study aimed to to identify reliable MN biomarkers and clarify underlying mechanisms,providing new approaches for precise diagnosis and treatment Methods Glomeruli from 5 MN patients and 8 normal controls were isolated via LCM and detected by LC-MRM-MS proteomics. We integrated GO/KEGG enrichment, PPI network, WGCNA, three machine learning algorithms to screen hub proteins. IHC and WB were used to verify candidate protein expression. Public single-cell dataset GSE241302 was applied for in silico knockdown simulation, and AutoDock Vina performed molecular docking to screen targeted small-molecule compounds. Results We identified 29 glomerular DEPs (18 upregulated, 11 downregulated) enriched in complement-coagulation, lipid metabolism, oxidative stress and ECM remodeling. PPI and WGCNA revealed APOE, FBLN1 and HP as core hub proteins. Three machine learning algorithms converged on HPT, FBLN1 and APOE as diagnostic markers with AUC>0.95. IHC and WB confirmed markedly higher glomerular APOE in MN (p = 0.0035, p < 0.0001). In silico APOE knockdown restored glutathione metabolism, detoxification, lipid signaling and tubular SLC transporters to relieve podocyte damage and proteinuria. Eight high-affinity APOE-targeted BRD compounds were screened via molecular docking, with BRD-K76617868 and BRD-K93023739 showing the best binding capacity. Conclusion APOE acts as a high-performance glomerular diagnostic biomarker and central pathogenic hub of MN, which mediates renal damage via crosstalk of lipid metabolism, immune inflammation, redox imbalance and tubular dysfunction. This research provides novel theoretical basis for non-invasive auxiliary diagnosis and molecular targeted therapy of MN

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11227389/v1
Primary Topic
Renal Diseases and Glomerulopathies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrated analysis of laser-captured glomerular proteome characterizes the expression and functional role of APOE in membranous nephropathy

Donge Tang, Huaizhou Chen, Hualin Ma, Yaoshuang Zou et al.
Research Square
Renal Diseases and Glomerulopathies
preprint

Integrated analysis of laser-captured glomerular proteome characterizes the expression and functional role of APOE in membranous nephropathy

Donge Tang, Huaizhou Chen, Hualin Ma, Yaoshuang Zou, Jingsheng Ma, Guimian Zou, Yong Dai, Jingjing Dong, Chang Lu, Shenping Xie, Guang Hu, Zhifeng Luo
preprint en

Abstract

Background MN is a prevalent primary glomerular disease causing adult nephrotic syndrome. Clinically, invasive renal biopsy acts as the pathological gold standard, while the widely used serological anti-PLA2R antibody has limited sensitivity and cannot reflect glomerular lesion severity. Conventional immunosuppressive regimens face frequent drug resistance and relapse, and core tissue-derived pathogenic regulators remain poorly defined. This study aimed to to identify reliable MN biomarkers and clarify underlying mechanisms,providing new approaches for precise diagnosis and treatment Methods Glomeruli from 5 MN patients and 8 normal controls were isolated via LCM and detected by LC-MRM-MS proteomics. We integrated GO/KEGG enrichment, PPI network, WGCNA, three machine learning algorithms to screen hub proteins. IHC and WB were used to verify candidate protein expression. Public single-cell dataset GSE241302 was applied for in silico knockdown simulation, and AutoDock Vina performed molecular docking to screen targeted small-molecule compounds. Results We identified 29 glomerular DEPs (18 upregulated, 11 downregulated) enriched in complement-coagulation, lipid metabolism, oxidative stress and ECM remodeling. PPI and WGCNA revealed APOE, FBLN1 and HP as core hub proteins. Three machine learning algorithms converged on HPT, FBLN1 and APOE as diagnostic markers with AUC>0.95. IHC and WB confirmed markedly higher glomerular APOE in MN (p = 0.0035, p < 0.0001). In silico APOE knockdown restored glutathione metabolism, detoxification, lipid signaling and tubular SLC transporters to relieve podocyte damage and proteinuria. Eight high-affinity APOE-targeted BRD compounds were screened via molecular docking, with BRD-K76617868 and BRD-K93023739 showing the best binding capacity. Conclusion APOE acts as a high-performance glomerular diagnostic biomarker and central pathogenic hub of MN, which mediates renal damage via crosstalk of lipid metabolism, immune inflammation, redox imbalance and tubular dysfunction. This research provides novel theoretical basis for non-invasive auxiliary diagnosis and molecular targeted therapy of MN

Research Square
Anhui University of Science and Technology (CN), ShenZhen People’s Hospital (CN), Chinese People's Liberation Army (CN)
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon